NCT00344760View on ClinicalTrials.gov

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
HIV Infections
Interventions
DRUG

Enfuvirtide

subcutaneously twice a day

DRUG

Efavirenz, lamivudine, and tenofovir

Efavirenz -600mg once daily, lamivudine- 300mg once daily, and tenofovir 300mg once daily

Trial Locations (1)

21201

University of Maryland, Institute of Human Virology, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00344760 - A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy | Biotech Hunter | Biotech Hunter